Spots Global Cancer Trial Database for myxoid liposarcoma
Every month we try and update this database with for myxoid liposarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial) | NCT03816475 | Myxoid Liposarc... | Hypofractionate... | 18 Years - | Maria Sklodowska-Curie National Research Institute of Oncology | |
| START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer | NCT05492682 | Melanoma (Skin) Triple-Negative... Non-Small Cell ... Synovial Sarcom... Myxoid Liposarc... Colorectal Canc... | PeptiCRAd-1 Cyclophosphamid... Pembrolizumab | 18 Years - | Valo Therapeutics Oy | |
| Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall | NCT03651375 | Sarcoma Fibrosarcoma Leiomyosarcoma Liposarcoma Myosarcoma Histiocytic Sar... Synovial Sarcom... Lymphangiosarco... Malignant Perip... Myxofibrosarcom... Myxoid Liposarc... Undifferentiate... Pleomorphic Lip... Undifferentiate... Dedifferentiate... Pleomorphic Rha... Malignant Trito... | Sequential chem... Hypofractionate... | 18 Years - 100 Years | Maria Sklodowska-Curie National Research Institute of Oncology | |
| Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas | NCT03600649 | Ewing Sarcoma Myxoid Liposarc... Sarcoma,Soft Ti... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Primary Pulmona... Myoepithelial T... Sclerosing Epit... Fibromyxoid Tum... | Seclidemstat Cyclophosphamid... Topotecan | 12 Years - | Salarius Pharmaceuticals, LLC | |
| Brostallicin Clinical Trial for Myxoid Liposarcoma | NCT00633165 | Myxoid Liposarc... | Brostallicin | 18 Years - | Systems Medicine LLC | |
| Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma | NCT02821507 | Conventional Ch... Myxoid Liposarc... Mesenchymal Cho... Dedifferentiate... | sirolimus and c... | 18 Years - | Leiden University Medical Center | |
| Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma | NCT03397186 | Myxoid Liposarc... Round Cell Lipo... Stage III Soft ... Stage IV Soft T... Metastatic Soft... Unresectable So... | Biopsy Laboratory Biom... Trabectedin | 18 Years - | Fred Hutchinson Cancer Center | |
| A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) | NCT05266196 | Ewing Sarcoma Myxoid Liposarc... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Myoepithelial T... Low Grade Fibro... Sclerosing Epit... | Seclidemstat | 12 Years - | Salarius Pharmaceuticals, LLC | |
| International Prospective Registry on Local Treatment Approaches in MLS | NCT04699292 | Myxoid Liposarc... | Surgery Preoperative RT... Preoperative RT... Postoperative R... RT 36Gy | 18 Years - | The Netherlands Cancer Institute | |
| International Prospective Registry on Local Treatment Approaches in MLS | NCT04699292 | Myxoid Liposarc... | Surgery Preoperative RT... Preoperative RT... Postoperative R... RT 36Gy | 18 Years - | The Netherlands Cancer Institute | |
| Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas | NCT03600649 | Ewing Sarcoma Myxoid Liposarc... Sarcoma,Soft Ti... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Primary Pulmona... Myoepithelial T... Sclerosing Epit... Fibromyxoid Tum... | Seclidemstat Cyclophosphamid... Topotecan | 12 Years - | Salarius Pharmaceuticals, LLC | |
| Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial) | NCT03816475 | Myxoid Liposarc... | Hypofractionate... | 18 Years - | Maria Sklodowska-Curie National Research Institute of Oncology | |
| A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) | NCT05266196 | Ewing Sarcoma Myxoid Liposarc... Desmoplastic Sm... Extraskeletal M... Angiomatoid Fib... Clear Cell Sarc... Myoepithelial T... Low Grade Fibro... Sclerosing Epit... | Seclidemstat | 12 Years - | Salarius Pharmaceuticals, LLC | |
| Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma | NCT01957709 | Myxoid Liposarc... Round Cell Lipo... Synovial Sarcom... | Laboratory Biom... Recombinant Int... | 18 Years - | Fred Hutchinson Cancer Center | |
| Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall | NCT03651375 | Sarcoma Fibrosarcoma Leiomyosarcoma Liposarcoma Myosarcoma Histiocytic Sar... Synovial Sarcom... Lymphangiosarco... Malignant Perip... Myxofibrosarcom... Myxoid Liposarc... Undifferentiate... Pleomorphic Lip... Undifferentiate... Dedifferentiate... Pleomorphic Rha... Malignant Trito... | Sequential chem... Hypofractionate... | 18 Years - 100 Years | Maria Sklodowska-Curie National Research Institute of Oncology |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
